These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36542313)

  • 1. In vitro fertilization: a cross-sectional analysis of 58 US insurance companies.
    Ha M; Drees A; Myers M; Finkelstein ER; Dandulakis M; Reindorf M; Roque DM; Beall SA; Slezak S; Rasko YM
    J Assist Reprod Genet; 2023 Mar; 40(3):581-587. PubMed ID: 36542313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of in vitro fertilization state mandates for third party insurance coverage in the United States: a review and critical assessment.
    Peipert BJ; Montoya MN; Bedrick BS; Seifer DB; Jain T
    Reprod Biol Endocrinol; 2022 Aug; 20(1):111. PubMed ID: 35927756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracytoplasmic sperm injection use in states with and without insurance coverage mandates for infertility treatment, United States, 2000-2015.
    Dieke AC; Mehta A; Kissin DM; Nangia AK; Warner L; Boulet SL
    Fertil Steril; 2018 Apr; 109(4):691-697. PubMed ID: 29580644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review of Insurance Coverage of Gender-Affirming Genital Surgery.
    Ngaage LM; Knighton BJ; Benzel CA; McGlone KL; Rada EM; Coon D; Bluebond-Langner R; Rasko YM
    Plast Reconstr Surg; 2020 Mar; 145(3):803-812. PubMed ID: 32097329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State-mandated insurance coverage is associated with the approach to hydrosalpinges before IVF.
    Omurtag K; Grindler NM; Roehl KA; Bates GW; Beltsos AN; Odem RR; Jungheim ES
    Reprod Biomed Online; 2014 Jul; 29(1):131-5. PubMed ID: 24813751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health Insurance Coverage of Gender-Affirming Top Surgery in the United States.
    Ngaage LM; Knighton BJ; McGlone KL; Benzel CA; Rada EM; Bluebond-Langner R; Rasko YM
    Plast Reconstr Surg; 2019 Oct; 144(4):824-833. PubMed ID: 31568285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Surgical Management of Migraines and Chronic Headaches: A Cross-sectional Review of American Insurance Coverage.
    Zhu K; Ha M; Finkelstein ER; Chaudry S; Hricz N; Ngaage LM; Rasko Y
    Ann Plast Surg; 2023 Jun; 90(6):592-597. PubMed ID: 37311314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A National Review of Insurance Coverage of Noncancerous Breast Reconstruction.
    Klein M; Ha M; Yang A; Ngaage LM; Slezak S; Rasko Y
    Ann Plast Surg; 2021 Sep; 87(3):232-237. PubMed ID: 34397512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and characteristics of patients declined from pursuing in vitro fertilization with autologous oocytes.
    Hariton E; Morris JR; Portugal A; Anderson-Bialis J; Anderson-Bialis D; Cedars MI
    J Assist Reprod Genet; 2021 Oct; 38(10):2679-2685. PubMed ID: 34374923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National Variation of Insurance Coverage for Gender-Affirming Facial Feminization Surgery.
    Gadkaree SK; DeVore EK; Richburg K; Lee LN; Derakhshan A; McCarty JC; Seth R; Shaye DA
    Facial Plast Surg Aesthet Med; 2021; 23(4):270-277. PubMed ID: 32865436
    [No Abstract]   [Full Text] [Related]  

  • 11. Navigating the Insurance Landscape for Coverage of Reduction Mammaplasty.
    Rawes CMA; Ngaage LM; Borrelli MR; Puthumana J; Slezak S; Rasko YM
    Plast Reconstr Surg; 2020 Nov; 146(5):539e-547e. PubMed ID: 33141528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insurance coverage and outcomes of in vitro fertilization.
    Jain T; Harlow BL; Hornstein MD
    N Engl J Med; 2002 Aug; 347(9):661-6. PubMed ID: 12200554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Great Recession, insurance mandates, and the use of in vitro fertilization services in the United States.
    Kiatpongsan S; Huckman RS; Hornstein MD
    Fertil Steril; 2015 Feb; 103(2):448-54. PubMed ID: 25497450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of American insurance coverage and criteria for conservative management of lymphedema.
    Finkelstein ER; Ha M; Hanwright P; Ngaage LM; Yoon JS; Liang F; Nam AJ; Rasko YM
    J Vasc Surg Venous Lymphat Disord; 2022 Jul; 10(4):929-936. PubMed ID: 35364303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with early in vitro fertilization treatment discontinuation.
    Bedrick BS; Anderson K; Broughton DE; Hamilton B; Jungheim ES
    Fertil Steril; 2019 Jul; 112(1):105-111. PubMed ID: 31043233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insurance Coverage of Dermabrasion and Chemical Peel Procedures: A Critical Analysis of 58 American Insurance Companies.
    Ha M; Finkelstein ER; Wieland M; Qadri A; Brown M; Ejimogu J; Rasko YM
    Cureus; 2022 Dec; 14(12):e33184. PubMed ID: 36726896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro fertilization and multiple pregnancies: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(18):1-63. PubMed ID: 23074488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of comprehensive state insurance mandates on in vitro fertilization utilization, embryo transfer practices, and outcomes in the United States.
    Peipert BJ; Chung EH; Harris BS; Jain T
    Am J Obstet Gynecol; 2022 Jul; 227(1):64.e1-64.e8. PubMed ID: 35283088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. US State-Level Infertility Insurance Mandates and Health Plan Expenditures on Infertility Treatments.
    Boulet SL; Kawwass J; Session D; Jamieson DJ; Kissin DM; Grosse SD
    Matern Child Health J; 2019 May; 23(5):623-632. PubMed ID: 30600516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of insurance mandates on choices and outcomes in infertility treatment markets.
    Hamilton BH; McManus B
    Health Econ; 2012 Aug; 21(8):994-1016. PubMed ID: 21905150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.